Labcorp Holdings Inc. (NYSE:LH) Q4 2025 Earnings Call Transcript February 17, 2026 Labcorp Holdings Inc. misses on earnings ...

Labcorp Holdings Inc. ( LH) Q4 2025 Earnings Call February 17, 2026 9:00 AM EST Good day, and thank you for standing by. Welcome to the Q4 2025 Labcorp Holdings Earnings Conference Call. [Operator ...

Labcorp Holdings Inc (LH) reports robust financial performance with significant revenue and EPS growth, driven by strategic acquisitions and new test launches.

For the quarter ended December 2025, Labcorp Holdings (LH) reported revenue of $3.52 billion, up 5.6% over the same period last year. EPS came in at $4.07, compared to $3.45 in the year-ago quarter.

Detailed price information for Laboratory Corp of America Holdings (LH-N) from The Globe and Mail including charting and trades.

Guidance for 2026 is for 5.4% midpoint revenue growth and 9% adjusted EPS growth, compared to 2025's 7% revenue and 13% EPS growth. Margin expansion continues, but with slightly moderated growth rates ...

ACA enrollment is over, but HCSMs provide vital year-round safety nets. Christian Care Health offers netWell™ as a top ...

Feb 10 () - Quest Diagnostics on Tuesday forecast 2026 profit and revenue above Wall Street ​estimates after beating ...

As a leading independent diagnostic laboratory, Labcorp participates in a highly attractive duopoly that offers favorable prospects as healthcare moves toward reformed payment models, another reprieve ...

WIPR has unveiled its latest USA Patents Rankings, a shortlist of the firms and lawyers at the forefront of the world’s most lucrative patent market.

Payer scrutiny in spine and orthopedic care is intensifying, and surgeons say the biggest barriers to care come not from clinical uncertainty, but from rigid algorithms, prior authorization delays and ...